Citations

Mayo Clinic

Showing 10 of 108523 citations.

Axitinib: from preclinical development to future clinical perspectives in renal cell carcinoma
Zakharia, Yousef , Zakharia, Kais , Rixe, Olivier , Zakharia, Yousef

Expert Opinion on Drug Discovery | June 3, 2015 | Volume: 10 | Issue: 8 | Pages: 925-935

10.1517/17460441.2015.1045411 | PMID 26039031 Get It

Pulmonary Hypertension in Patients Undergoing Transcatheter Aortic Valve Replacement
Gössl, Mario , Kane, Garvan C. , Mauermann, William J., Holmes, David R. , Mauermann, William

Circulation: Cardiovascular Interventions | June 3, 2015 | Volume: 8 | Issue: 6 | Pages: No page available

10.1161/circinterventions.114.002253 | PMID 26038483 Get It

Age and Sex Differences in Long‐Term Outcomes Following Implantable Cardioverter‐Defibrillator Placement in Contemporary Clinical Practice: Findings From the Cardiovascular Research Network
Masoudi, Frederick A. , Go, Alan S. , Magid, David J. , Gurwitz, Jerry H. , Liu, Taylor I. , Smith, David H. , Reifler, Liza M. , Glenn, Karen A., Fiocchi, Frances, Gupta, Nigel, Peterson, Pamela N., Schuger, Claudio , Vidaillet, Humberto, Hammill, Stephen C., Greenlee, Robert T. , Cassidy‐Bushrow, Andrea E. , Liu, Taylor , Reynolds, Kristi , Goldberg, Robert Joel , Peterson, Pamela N.

Journal of the American Heart Association | June 3, 2015 | Volume: 4 | Issue: 6 | Pages: No page available

10.1161/jaha.115.002005 | PMID 26037083 Get It

Background Patient sex and age may influence rates of death after receiving an implantable cardioverter‐defibrillator for primary prevention. Differences in outcomes other than mortality and whether these differences vary by heart failure symptoms, etiology, and left ventricular ejection fraction are not well characterized. Methods and Results We studied 2954 patients with left ventricular ejection fraction ≤0.35 undergoing first‐time implantable cardioverter‐defibrillator for primary prevention within the Cardiovascular Research Network; 769 patients (26%) were women, and 2827 (62%) were aged >65 years. In a median follow‐up of 2.4 years, outcome rates per 1000 patient‐years were 109 for death, 438 for hospitalization, and 111 for heart failure hospitalizations. Procedure‐related complications occurred in 8.36%. In multivariable models, women had significantly lower risks of death (hazard ratio 0.67, 95% CI 0.56 to 0.80) and heart failure hospitalization (hazard ratio 0.82, 95% CI 0.68 to 0.98) and higher risks for complications (hazard ratio 1.38, 95% CI 1.01 to 1.90) than men; patients aged >65 years had higher risks of death (hazard ratio 1.55, 95% CI 1.30 to 1.86) and heart failure hospitalization (hazard ratio 1.25, 95% CI 1.05 to 1.49) than younger patients. Age and sex differences were generally consistent in strata according to symptoms, etiology, and severity of left ventricular systolic dysfunction, except the higher risk of complications in women, which differed by New York Heart Association classification ( P =0.03 for sex–New York Heart Association interaction), and the risk of heart failure hospitalization in older patients, which differed by etiology of heart failure ( P =0.05 for age–etiology interaction). Conclusions The burden of adverse outcomes after receipt of an implantable cardioverter‐defibrillator for primary prevention is substantial and varies according to patient age and sex. These differences in outcome generally do not vary according to baseline heart failure characteristics.
Association between Body Mass Index and Mortality for Colorectal Cancer Survivors: Overall and by Tumor Molecular Phenotype
Newton, Christina C. , Phipps, Amanda I. , Ahnen, Dennis J. , Buchanan, Daniel D. , Cleary, Sean P. , Farris, Alton B. , Figueiredo, Jane C. , Gallinger, Steven, Green, Roger C., Haile, Robert W. , Jenkins, Mark A. , Makar, Karen W., McLaughlin, John R., Potter, John D. , Thibodeau, Stephen N. , Win, Aung Ko , Lindor, Noralane M. , Limburg, Paul J. , Campbell, Peter T. , Newcomb, Polly A. , Baron, John A. , Casey, Graham , Cotterchio, Michelle , Hopper, John L. , Marchand, Loı̈c Le , McLaughlin, John R., Renehan, Andrew G. , Sinicrope, Frank A. , Ulrich, Cornelia M. , Buchanan, Daniel D , Win, Aung K , Jenkins, Mark A , Haile, Robert W , Potter, John D , Farris, Alton B , Cleary, Sean P

Cancer Epidemiology, Biomarkers & Prevention | June 3, 2015 | Volume: 24 | Issue: 8 | Pages: 1229-1238

10.1158/1055-9965.epi-15-0094 | PMID 26038390 Get It

Abstract Background: Microsatellite instability (MSI) and BRAF mutation status are associated with colorectal cancer survival, whereas the role of body mass index (BMI) is less clear. We evaluated the association between BMI and colorectal cancer survival, overall and by strata of MSI, BRAF mutation, sex, and other factors. Methods: This study included 5,615 men and women diagnosed with invasive colorectal cancer who were followed for mortality (maximum: 14.7 years; mean: 5.9 years). Prediagnosis BMI was derived from self-reported weight approximately one year before diagnosis and height. Tumor MSI and BRAF mutation status were available for 4,131 and 4,414 persons, respectively. Multivariable hazard ratios (HR) and 95% confidence intervals (CI) were estimated from delayed-entry Cox proportional hazards models. Results: In multivariable models, high prediagnosis BMI was associated with higher risk of all-cause mortality in both sexes (per 5-kg/m2; HR, 1.10; 95% CI, 1.06–1.15), with similar associations stratified by sex (Pinteraction: 0.41), colon versus rectum (Pinteraction: 0.86), MSI status (Pinteraction: 0.84), and BRAF mutation status (Pinteraction: 0.28). In joint models, with MS-stable/MSI-low and normal BMI as the reference group, risk of death was higher for MS-stable/MSI-low and obese BMI (HR, 1.32; P value: 0.0002), not statistically significantly lower for MSI-high and normal BMI (HR, 0.86; P value: 0.29), and approximately the same for MSI-high and obese BMI (HR, 1.00; P value: 0.98). Conclusions: High prediagnosis BMI was associated with increased mortality; this association was consistent across participant subgroups, including strata of tumor molecular phenotype. Impact: High BMI may attenuate the survival benefit otherwise observed with MSI-high tumors. Cancer Epidemiol Biomarkers Prev; 24(8); 1229–38. ©2015 AACR.
The Minimal Clinically Important Difference in Vestibular Schwannoma Quality‐of‐Life Assessment
Carlson, Matthew L. , Tveiten, Øystein Vesterli , Yost, Kathleen J. , Lohse, Christine M. , Lund‐Johansen, Morten , Link, Michael J.

Otolaryngology–Head and Neck Surgery | June 2, 2015 | Volume: 153 | Issue: 2 | Pages: 202-208

10.1177/0194599815585508 | PMID 26038393 Get It

ObjectiveSeveral studies have demonstrated small but statistically significant differences in quality‐of‐life (QOL) scores among vestibular schwannoma (VS) treatment modalities. However, does a several‐point difference on a 100‐point scale really matter? The minimal clinically important difference (MCID)—defined as the smallest difference in scores that patients perceive as important and that could lead to a change in management—was developed to answer this important question. While the MCID has been determined for QOL measures used in other diseases, it remains undefined in the VS literature.Study DesignDistribution‐ and anchor‐based techniques were utilized to define the MCID for the Penn Acoustic Neuroma Quality of Life (PANQOL) and 36‐Item Short Form Health Survey (SF‐36).SettingTwo academic referral centers.PatientsPatients with VS (N = 538).InterventionCross‐sectional postal survey.Main Outcome MeasuresMCID for PANQOL domains and total score and SF‐36 Physical and Mental Health Component Summary scores.ResultsThe MCID (median, interquartile range) for the PANQOL total score was 11 points (10‐12); the MCIDs for individual domains were as follows: hearing, 6 (5‐8); balance, 16 (14‐19); facial, 10 (no interquartile range); pain, 11 (10‐13); energy, 13 (10‐17); anxiety, 11 (5‐22); and general, 15 (11‐19). The MCID was 7 points (6‐11) for the SF‐36 Mental Health Component Summary score and 8 points (6‐10) for the Physical Health Component Summary score.ConclusionsThe MCIDs determined in the current study generally exceed differences reported in previous prospective studies, in which conclusions about QOL benefit (or harm) among VS treatment modalities were based on statistical significance alone. Moving forward, these MCIDs should be considered when interpreting results of VS QOL studies.
The Profile of Long-term Parkinson’s Disease Survivors with 20 Years of Disease Duration and Beyond
Hassan, Anhar , Wu, Samuel S. , Schmidt, Péter , Simuni, Tanya , Miyasaki, Janis M. , Bloem, Bastiaan R. , Okun, Michael S. , Investigators, on behalf of the NPF QII, Giladi, Nir , Malaty, Irene A. , Investigators, on behalf of the NPF QII, Okun, Michael S , Simuni, Tanya

Journal of Parkinson’s Disease | June 2, 2015 | Volume: 5 | Issue: 2 | Pages: 313-319

10.3233/jpd-140515 | PMID 25720446 Get It

Background: Parkinson’s disease (PD) patients with 20 years or more survival (PD-20) are not well characterized. Objective: To evaluate PD-20 patient characteristics and identify areas for improvement of their health care. Methods: The international, multicenter National Parkinson’s Foundation Quality Improvement Initiative (NPF-QII) study database was queried to identify PD-20 subjects. Demographic and clinical data were analyzed. Results: We identified 187 PD-20 subjects (55% men) representing 4% (187/4,619) of all NPF-QII participants. Subjects were mean age 69.5 years; mean age at PD onset was 44.0 years. The majority (75%) had 20-25 years of PD duration, the longest duration being 49 years. They were median Hoehn and Yahr stage 3, and 75% had motor fluctuations. Half (54%) reported exercising. The majority (89%) were living at home and required a caregiver (88%). They were mildly cognitively impaired for age (Montreal Cognitive Assessment estimate 22.6±3.7), with most deficits in verbal fluency and delayed recall. Quality of life (Parkinson’s Disease Quality of Life Questionnaire index 36±15%) was mild to moderately impaired, with most impairment in mobility and activities of daily living. Caregiver strain measured by the Multidimensional Caregiver Strain Index (27±16%), recorded highest subscores in social constraint. PD-20 subjects aged <70 years versus ≥70 only differed significantly by worse cognition ( P < 0.0001). Conclusions: PD-20 subjects reflect an elite group of PD survivors with early-onset disease and relatively mild cognitive disability despite long disease duration. Interventions for caregivers, mobility, and activities of daily living are areas that could improve caregiver burden and patient quality of life.
Ankle mechanics during sidestep cutting implicates need for 2-degrees of freedom powered ankle-foot prostheses
Ficanha, Evandro M., Rastgaar, Mo , Kaufman, Kenton R. , Kaufman, Kenton R

Journal of Rehabilitation Research and Development | June 2, 2015 | Volume: 52 | Issue: 1 | Pages: 97-112

10.1682/jrrd.2014.02.0043 | PMID 26186014 Get It

Exercise, cognitive function, and aging
Barnes, Jill N. , Barnes, J N

Advances in Physiology Education | June 2, 2015 | Volume: 39 | Issue: 2 | Pages: 55-62

10.1152/advan.00101.2014 | PMID 26031719 Get It

Increasing the lifespan of a population is often a marker of a country's success. With the percentage of the population over 65 yr of age expanding, managing the health and independence of this population is an ongoing concern. Advancing age is associated with a decrease in cognitive function that ultimately affects quality of life. Understanding potential adverse effects of aging on brain blood flow and cognition may help to determine effective strategies to mitigate these effects on the population. Exercise may be one strategy to prevent or delay cognitive decline. This review describes how aging is associated with cardiovascular disease risks, vascular dysfunction, and increasing Alzheimer's disease pathology. It will also discuss the possible effects of aging on cerebral vascular physiology, cerebral perfusion, and brain atrophy rates. Clinically, these changes will present as reduced cognitive function, neurodegeneration, and the onset of dementia. Regular exercise has been shown to improve cognitive function, and we hypothesize that this occurs through beneficial adaptations in vascular physiology and improved neurovascular coupling. This review highlights the potential interactions and ideas of how the age-associated variables may affect cognition and may be moderated by regular exercise.
A Large Multiethnic Genome-Wide Association Study of Prostate Cancer Identifies Novel Risk Variants and Substantial Ethnic Differences
Hoffmann, Thomas J. , Jorgenson, Eric , Habel, Laurel A. , Passarelli, Michael N. , Cario, Clinton L. , Emami, Nima C. , Chao, Chun , Ghai, Nirupa R. , Shan, Jun , Ranatunga, Dilrini K., Aaronson, David S., Presti, Joseph C. , Berndt, Sonja I. , McDonnell, Shannon K. , French, Amy J. , Schaid, Daniel J. , Thibodeau, Stephen N. , Freedman, Matthew L. , Mucci, Lorelei A. , Haiman, Christopher A. , Henderson, Brian E., Seminara, Daniela, Kvale, Mark , Schaefer, Catherine , Risch, Neil , Witte, John S. , Wang, Zhaoming , Van Den Eeden, Stephen K , Sakoda, Lori C. , Graff, Rebecca E. , Quesenberry, Charles P. , Wang, Zhaoming , Chanock, Stephen Jacob , Li, Qiyuan , Penney, Kathryn , Kwok, Pui–Yan , Wang, Zhaoming , McDonnell, Shannon K

Cancer Discovery | June 2, 2015 | Volume: 5 | Issue: 8 | Pages: 878-891

10.1158/2159-8290.cd-15-0315 | PMID 26034056 Get It

Abstract A genome-wide association study (GWAS) of prostate cancer in Kaiser Permanente health plan members (7,783 cases, 38,595 controls; 80.3% non-Hispanic white, 4.9% African-American, 7.0% East Asian, and 7.8% Latino) revealed a new independent risk indel rs4646284 at the previously identified locus 6q25.3 that replicated in PEGASUS (N = 7,539) and the Multiethnic Cohort (N = 4,679) with an overall P = 1.0 × 10−19 (OR, 1.18). Across the 6q25.3 locus, rs4646284 exhibited the strongest association with expression of SLC22A1 (P = 1.3 × 10−23) and SLC22A3 (P = 3.2 × 10−52). At the known 19q13.33 locus, rs2659124 (P = 1.3 × 10−13; OR, 1.18) nominally replicated in PEGASUS. A risk score of 105 known risk SNPs was strongly associated with prostate cancer (P &lt; 1.0 × 10−8). Comparing the highest to lowest risk score deciles, the OR was 6.22 for non-Hispanic whites, 5.82 for Latinos, 3.77 for African-Americans, and 3.38 for East Asians. In non-Hispanic whites, the 105 risk SNPs explained approximately 7.6% of disease heritability. The entire GWAS array explained approximately 33.4% of heritability, with a 4.3-fold enrichment within DNaseI hypersensitivity sites (P = 0.004). Significance: Taken together, our findings of independent risk variants, ethnic variation in existing SNP replication, and remaining unexplained heritability have important implications for further clarifying the genetic risk of prostate cancer. Our findings also suggest that there may be much promise in evaluating understudied variation, such as indels and ethnically diverse populations. Cancer Discov; 5(8); 878–91. ©2015 AACR. This article is highlighted in the In This Issue feature, p. 783
Has Diagnostic (Analytic) Accuracy Improved in Anatomic Pathology? Are We Better Today Than We Were 20 Years Ago?
Nakhleh, Raouf E.

Archives of Pathology & Laboratory Medicine | June 2, 2015 | Volume: 139 | Issue: 6 | Pages: 716-718

10.5858/arpa.2015-0013-ed | PMID 26030238 Get It